Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Vergiss die Indizes - Forge steigt um 40 %, während der S&P & Dow fällt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWWY | ISIN: US92859E2072 | Ticker-Symbol:
NASDAQ
24.04.25
22:00 Uhr
2,710 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVOS THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
VIVOS THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur VIVOS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.04.Vivos Therapeutics, Inc. - 8-K, Current Report3
16.04.Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada1
16.04.Vivos Therapeutics, Inc: Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada64By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to...
► Artikel lesen
31.03.Vivos Therapeutics, Inc. - 8-K, Current Report1
VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln
31.03.Vivos Therapeutics GAAP EPS of -$2.22 misses by $0.20, revenue of $15.03M misses by $0.17M5
31.03.Vivos Therapeutics, Inc: Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update49Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo....
► Artikel lesen
31.03.Vivos Therapeutics, Inc. - 10-K, Annual Report3
28.03.Earnings Outlook For Vivos Therapeutics2
18.02.Vivos Therapeutics, Inc: Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.1
14.02.Vivos Therapeutics, Inc. - 8-K, Current Report-
11.02.Vivos Therapeutics announces up to $50M mixed shelf offering1
29.01.Vivos Therapeutics, Inc. - S-1/A, General form for registration of securities-
22.01.Vivos Therapeutics announces sale of up to 854,332 shares by selling stockholders1
22.01.Vivos Therapeutics, Inc. - S-1, General form for registration of securities-
23.12.24Vivos Therapeutics, Inc. - 8-K, Current Report-
23.12.24Vivos Therapeutics announces $3.5 million stock offering2
23.12.24Vivos Therapeutics kündigt Aktienemission im Wert von 3,5 Millionen US-Dollar an3
23.12.24Vivos Therapeutics, Inc: Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules1
10.12.24Cellev8 Nutrition Inc: Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress429WELLINGTON, FL and HIGHLANDS RANCH, CO / ACCESSWIRE / December 10, 2024 / Cellev8 Nutrition Inc. (OTC Pink:CELV) and Vivos Therapeutics, Inc. today announced a strategic joint marketing venture aimed...
► Artikel lesen
27.11.24Vivos Therapeutics, Inc. - 8-K, Current Report1
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1